Antibacterial effect of bismuth subsalicylate nanoparticles synthesized by laser ablation
- 299 Downloads
The antimicrobial properties of bismuth subsalicylate (BSS) nanoparticles against four opportunistic pathogens; E. coli, P. aeruginosa, S. aureus, and S. epidermidis were determined. BSS nanoparticles were synthesized by pulse laser ablation of a solid target in distilled water under different conditions. The nanoparticles were characterized using high-resolution transmission electron microscopy and absorption spectra and small angle X-ray scattering. The analysis shows that the colloids maintained the BSS structure and presented average particle size between 20 and 60 nm, while the concentration ranges from 95 to 195 mg/L. The antibacterial effect was reported as the inhibition ratio of the bacterial growth after 24 h and the cell viability was measured using the XTT assay. The results showed that the inhibition ratio of E. coli and S. epidermidis was dependant on the NPs size and/or concentration, meanwhile P. aeruginosa and S. aureus were more sensitive to the BSS nanoparticles independently of both the size and the concentration. In general, the BSS colloids with average particle size of 20 nm were the most effective, attaining inhibition ratios >80 %, similar or larger than those obtained with the antibiotic used as control. The results suggest that the BSS colloids could be used as effective antibacterial agents with potential applications in the medical area.
KeywordsBismuth subsalicylate Nanoparticles Laser ablation Antimicrobial effect Health effects
The authors thank María de Jesús Salinas Nájera and Hermilo Zarco for their technical assistance. Supported by DGAPA-PAPIIT #IN18814, #IN118914, and CONACYT 152995 grants.
- Andreasen JJ, Andersen LP (1987) In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics. Acta Pathologica, Microbiologica, et Immunologica Scandinavica Sect B 95:147–149Google Scholar
- DuPont HL (1987) Bismuth subsalicylate in the treatment and prevention of diarrheal disease. Drug Intell Clin Pharm 21:687–693Google Scholar
- DuPont HL, Sullivan P, Pickering LK, Haynes G, Ackerman PB (1977) Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 73:715–718Google Scholar
- Harris LG, Foster SJ, Richards RG (2002) An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. Eur Cell Mater 4:39–60Google Scholar
- Mahony DE, Woods A, Eelman MD, Burford N, Veldhuyzen van Zanten SJ (2005) Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile. Antimicrob Agents Chemother 49:431–433. doi: 10.1128/AAC.49.1.431-433.2005 CrossRefGoogle Scholar
- Markowska K, Grudniak AM, Wolska KI (2013) Silver nanoparticles as an alternative strategy against bacterial biofilms. Acta Biochim Pol 60:523–530Google Scholar
- Pardo OA, Pardo Castello V (1952) The treatment of early syphilis with penicillin and bismuth subsalicylate; follow-up report. Am J Syph Gonorrhea Vener Dis 36:342–345Google Scholar
- Purvis JE (1927) The absorption spectra of various alkaloids and their salicylates and of derivatives of salicylic acid. J Chem Soc:2715-2719Google Scholar
- Steinhoff MC, Douglas RG Jr, Greenberg HB, Callahan DR (1980) Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology 78:1495–1499Google Scholar
- Tramontina VA, Machado MA, Nogueira Filho Gda R, Kim SH, Vizzioli MR, Toledo S (2002) Effect of bismuth subgallate (local hemostatic agent) on wound healing in rats. Histol Histometric Find Braz Dent J 13:11–16Google Scholar